These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22226343)

  • 1. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
    Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV
    Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
    Lesem MD; Tran-Johnson TK; Riesenberg RA; Feifel D; Allen MH; Fishman R; Spyker DA; Kehne JH; Cassella JV
    Br J Psychiatry; 2011 Jan; 198(1):51-8. PubMed ID: 21200077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Montañés F; Dobrovolskaya N; Bukhanovskaya O; Popov M; Vieta E
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):710-718. PubMed ID: 29724638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy review of inhaled loxapine for treatment of agitation.
    Currier G; Walsh P
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):25-32. PubMed ID: 23538290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
    de Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; Valchera A; Carano A; Vellante F; Marini S; Piersanti M; Perna G; Martinotti G; Di Giannantonio M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.
    Pollack CV
    Curr Med Res Opin; 2016 Jul; 32(7):1253-60. PubMed ID: 27121764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial.
    Gil E; Garcia-Alonso F; Boldeanu A; Baleeiro Teixeira T;
    BMJ Open; 2018 Oct; 8(10):e020242. PubMed ID: 30282677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.
    Keating GM
    CNS Drugs; 2013 Jun; 27(6):479-89. PubMed ID: 23740380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
    Gross N; Greos LS; Meltzer EO; Spangenthal S; Fishman RS; Spyker DA; Cassella JV
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):478-87. PubMed ID: 24745666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.